Growth Metrics

Conmed (CNMD) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 76.54%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 76.54%
Dec 31, 2025 81.66%
Sep 30, 2025 27.51%
Jun 30, 2025 15.84%
Mar 31, 2025 402.16%
Dec 31, 2024 8.65%
Sep 30, 2024 33.83%
Jun 30, 2024 8.10%
Mar 31, 2024 9.23%
Dec 31, 2023 40.94%
Sep 30, 2023 9.51%
Jun 30, 2023 68.87%
Mar 31, 2023 -44.77%
Dec 31, 2022 -31.69%
Sep 30, 2022 -10.90%
Jun 30, 2022 -4.59%
Mar 31, 2022 27.73%
Dec 31, 2021 11.00%
Sep 30, 2021 69.96%
Jun 30, 2021 18.45%
Mar 31, 2021 -3.70%
Dec 31, 2020 -1.08%
Sep 30, 2020 37.79%
Jun 30, 2020 -29.82%
Mar 31, 2020 -37.58%
Dec 31, 2019 43.99%
Sep 30, 2019 13.91%
Jun 30, 2019 6.26%
Mar 31, 2019 38.14%
Dec 31, 2018 26.52%
Sep 30, 2018 -31.71%
Jun 30, 2018 26.26%
Mar 31, 2018 19.11%
Dec 31, 2017 -6.73%
Sep 30, 2017 -2.79%
Jun 30, 2017 26.66%
Mar 31, 2017 -3.50%
Dec 31, 2016 -20.56%
Sep 30, 2016 -6.70%
Jun 30, 2016 0.57%
Mar 31, 2016 -71.29%
Dec 31, 2015 -28.90%
Sep 30, 2015 -21.26%
Jun 30, 2015 -26.35%
Mar 31, 2015 24.74%
Dec 31, 2014 -0.81%
Sep 30, 2014 -26.28%
Jun 30, 2014 -26.07%
Mar 31, 2014 -6.31%
Dec 31, 2013 5.97%
Sep 30, 2013 46.14%